The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 11, 2024

Filed:

Jul. 07, 2020
Applicant:

The Usa, As Represented BY the Secretary, Dept. of Health and Human Services, Bethesda, MD (US);

Inventors:

Masaru Kanekiyo, North Bethesda, MD (US);

Gary J. Nabel, Chestnut Hill, MA (US);

Jeffrey Cohen, Silver Springs, MD (US);

Wei Bu, Potomac, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/245 (2006.01); A61K 39/12 (2006.01); C07K 14/00 (2006.01); C07K 14/005 (2006.01); C07K 14/195 (2006.01); C07K 16/08 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/245 (2013.01); A61K 39/12 (2013.01); C07K 14/00 (2013.01); C07K 14/005 (2013.01); C07K 14/195 (2013.01); C07K 16/085 (2013.01); C12N 7/00 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/575 (2013.01); A61K 2039/64 (2013.01); C07K 2317/33 (2013.01); C07K 2317/76 (2013.01); C07K 2319/00 (2013.01); C07K 2319/40 (2013.01); C07K 2319/735 (2013.01); C12N 2710/16222 (2013.01); C12N 2710/16234 (2013.01); C12N 2710/16271 (2013.01);
Abstract

Vaccines are provided that elicit neutralizing antibodies to Epstein-Barr virus (EBV). Some vaccines comprise nanoparticles that display envelope proteins from EBV on their surface. The nanoparticles comprise fusion proteins comprising a monomeric subunit of a self-assembly protein, such as ferritin, joined to at least a portion of an EBV envelope protein. The fusion proteins self-assemble to form the envelope protein-displaying nanoparticles. Such vaccines can be used to vaccinate an individual against infection by different types of Epstein-Barr viruses as well as Epstein-Barr viruses that are antigenically divergent from the virus from which the EBV envelope protein was obtained. Also provided are fusion proteins and nucleic acid molecules encoding such proteins.


Find Patent Forward Citations

Loading…